(S (NP-SBJ (JJ Nuclear) (NN factor) (NN kappa) (NN B)) (VP (VBZ activates) (NP (NP (NN proenkephalin) (NN transcription)) (PP (IN in) (NP (NN T) (NNS lymphocytes))))) (. .))
(S (PP-TMP (IN Upon) (NP (NN activation))) (, ,) (NP-SBJ (NN T) (NNS lymphocytes)) (VP (VBP accumulate) (NP (NP (JJ high) (NNS levels)) (PP (IN of) (NP (DT the) (NN neuropeptide) (NN enkephalin))) (SBAR (WHNP-72 (WDT which)) (S (NP-SBJ (-NONE- *T*-72)) (VP (VBP correlate) (PP (IN with) (NP (NP (JJ high) (NNS levels)) (PP (IN of) (NP (NN proenkephalin) (NN mRNA))) (PP (IN in) (NP (DT the) (NNS cells)))))))))) (. .))
(S (ADVP (RB Here)) (NP-SBJ (PRP we)) (VP (VBD investigated) (NP (NP (DT the) (JJ transcriptional) (NN basis)) (PP (IN for) (NP (DT these) (NNS changes))))) (. .))
(S (NP-SBJ (DT The) (NN proenkephalin) (NN promoter)) (VP (VBZ contains) (NP (NP (DT a) (NN sequence) (NN GGGGACGTCCCC)) (, ,) (VP (VBN named) (S (NP-SBJ (-NONE- *)) (NP-PRD (NN B2)))) (, ,) (SBAR (WHNP-73 (WDT which)) (S (NP-SBJ (-NONE- *T*-73)) (VP (VBZ is) (ADJP-PRD (JJ similar) (PP (TO to) (NP (NP (DT the) (NN kappa) (NN B) (NN sequence) (NN GGGGACTTTCC)) (, ,) (NP (NP (DT the) (VBG binding) (NN site)) (PP (IN of) (NP (DT the) (NN transcription) (NN factor) (NP (NP (JJ nuclear) (NN factor)) (PRN (-LRB- -LRB-) (NP (NN NF)) (-RRB- -RRB-)) (NN -kappa) (NN B))))))))))))) (. .))
(S (NP-SBJ (NP (NN Activation)) (PP (IN of) (NP (NN T) (NNS lymphocytes)))) (VP (VBZ induces) (NP (DT an) (ADJP (NN NF-kappa) (JJ B-like)) (NN binding) (NN activity)) (PP (TO to) (NP (DT the) (NN B2) (NN site))) (, ,) (S (NP-SBJ (-NONE- *)) (ADJP-PRD (JJ concomitant) (PP (IN with) (NP (NP (NN activation)) (PP (IN of) (NP (DT the) (NN proenkephalin) (NN promoter)))))))) (. .))
(S (NP-SBJ (NP (NNS Mutations)) (PP (IN at) (NP (DT the) (NN B2) (NN site)))) (VP (VBP abolish) (NP (DT this) (JJ transcriptional) (NN activation))) (. .))
(S (NP-SBJ (NP (NP (DT The) (VBN purified) (NN homodimer)) (PRN (-LRB- -LRB-) (NP (CD two) (NNS p50s)) (-RRB- -RRB-))) (PP (IN of) (NP (NP (DT the) (JJ DNA-binding) (NN subunit)) (PP (IN of) (NP (NN NF-kappa) (NN B)))))) (VP (VBZ binds) (NP (NP (DT the) (NN B2) (NN site)) (PP (IN of) (NP (NN proenkephalin)))) (ADVP (ADVP (RB relatively) (JJR better)) (SBAR (IN than) (SINV (VBZ does) (NP-SBJ (NP (DT the) (NP (NP (NN heterotetramer)) (PRN (-LRB- -LRB-) (NP-COOD (NP (CD two) (NNS p65s)) (CC plus) (NP (CD two) (NNS p50s))) (-RRB- -RRB-))) (NN form)) (PP (IN of) (NP (DT the) (NN factor)))) (VP (-NONE- *?*)))))) (. .))
(S (ADVP (RB Thus)) (, ,) (NP-SBJ (PRP it)) (VP (VBZ appears) (SBAR (IN that) (S (NP-SBJ-74 (NP (DT the) (JJ T-cell-specific) (NN activation)) (PP (IN of) (NP (DT the) (NN proenkephalin) (NN promoter)))) (VP (VBZ is) (VP (VBN mediated) (NP (-NONE- *-74)) (PP (IN by) (NP-LGS (NN NF-kappa) (NN B)))))))) (. .))
(S (ADVP (RB However)) (, ,) (SBAR-ADV (IN as) (S-COOD (S (NP-SBJ (NN NF-kappa) (NN B)) (VP (VBZ is) (ADJP-PRD (JJ ubiquitous)))) (CC and) (S (NP-SBJ (NP (DT the) (JJ transcriptional) (NN activation)) (PP (IN through) (NP (DT the) (NN B2) (NN site)))) (VP (VBZ is) (ADJP-PRD (NP (NN T) (NN cell)) (JJ specific)))))) (, ,) (NP-SBJ-75 (NP (RB yet) (DT another) (JJ T-cell-specific) (NN factor)) (SBAR (WHNP-76 (WDT which)) (S (NP-SBJ (-NONE- *T*-76)) (VP (VBZ synergizes) (PP (IN with) (NP (NN NF-kappa) (NN B))))))) (VP (MD should) (VP (VB be) (VP (VBN considered) (NP (-NONE- *-75))))) (. .))
